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Background: H. influenzae is a natural competent bacterium that can uptake DNA from the environment and
recombine into bacterial genome. The outbreaks of Brazilian purpuric fever, heavily polluted areas of a different
H. influenzae biogroup - aegyptius - as well as gene transference between Neisseria meningitis make the transformation
process an important evolutionary factor. This work studied the horizontal transference of the ompP2 gene from a
multiresistant strain of H. influenzae 07 (NTHi), under the influence of graphene oxide nanoparticles in order to mimic
an atmosphere rich in suspended particles and this way verify if the CFU transformants number was increased.
Material and methods: In this article the gene ompP2 was transformed into different strains of H. influenzae mediated
or not by graphene oxide nanoparticles in suspension, followed by the adhesion tests in Hec-1B (human endometrium
adenocarcinoma) and A549 (pulmonary epithelial carcinoma) cells lines. The transformation frequency and the
adhesion capacity were determined in all the mutants to which the ompP2 gene was transferred and compared to
their wild type strains.
Results: The nanoparticles increased the transformation ratio of one particular strain isolated from a pneumonia case.
The adhesion patterns to A549 and Hec1b cell lines of these mutated bacteria has their capacity increased when
compared to the wild type.
Conclusions: Graphene oxide nanoparticles aid the transformation process, helping to increase the number of CFUs,
and the mutants generated with the ompP2 gene from a H. influenzae resistant strain not only present a
chloramphenicol resistance but also have an increased adherence patterns in A549 and Hec1B cell lines.
Keywords: Haemophilus influenzae, Graphene oxide, Bacterial transformation, Outer membrane protein, Virulence, PorinBackground
Haemophilus influenzae is a gram-negative pleomorphic
cocobacillus that usually colonizes the upper respiratory
tract in humans. This specie can be classified by two
methods: biotypes and serotypes. The division into bio-
types is based on the presence and production of enzymes
such as ornithine descarboxylase, urease and those that act* Correspondence: mlancell@unicamp.br
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unless otherwise stated.on fermentation of D-xylose and on the production of
indol. With this classification, Haemophilus influenzae can
be divided into 9 biotypes: I to VIII and aegyptius [1,2].
H. influenzae can also be classified based on the produc-
tion of a polyssacharide capsule composed by a 3-β-ribose-
(1-1)-ribitol-phosphate polymer (RPR), whose antigenic
structure divides the capsulated strains into 6 immunologic
known serotypes: a – f [3] and non-typed strains, which
do not produce capsule [4]. Other methods such as
membrane protein analysis, lipopolysaccharide profile
and isoenzymes electrophoresis can be used for thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of H. influenzae [5].
H. influenzae type b is the most invasive of all sero-
types and known as the main causer of meningitis, as
well as the most relevant pathogen of the upper respira-
tory tract in children and in adults [6-9]. H. influenzae is
responsible for 30 to 50% of all bacterial meningitis over
the world and the second most common agent of pneumo-
nia in children [10]. The non-typed forms of H. influenzae
(NTHi) are generally associated to moderate diseases
of the upper respiratory tract in children and pneu-
monia in adults with Chronic Obstructive Pulmonary
Disease (COPD) or Cystic Fibrosis [11]. The polyssac-
charidic capsule is considered the main antigen of this
microorganism [3]. Another important pathogen factor is
the lipopolyssacharides (LPS) associated with outer mem-
brane proteins (OMP), which causes high fever and
coagulation disorders [12].
H. influenzae resistance to antibiotics increased signifi-
cantly over the last 20 years. This resistance is worse to
beta-lactamic drugs, due to their production of beta-
lactamase [13]. Since the first reports of H. influenzae
resistant strains to ampicillin in 1974 in the USA, the
main proposed mechanism was the production of beta-
lactamases TEM-1 and ROB-1 by plasmids. The preva-
lence of beta-lactamase producing strains increased 15,
2% from 1983 to 1984 and 31, 3% from 1997 to 1998. H.Figure 1 Field emission electron microscopy show in different size an
B: micrometric scale and C: nanometric scale).influenzae is not only resistant to ampicillin; they also
present non-susceptibility to cephalosporin, trimethoprim,
cephalosporin, tetracycline and sulfonamides [14-17].
One of the main reasons for the emergence of multire-
sistant strains over the last years is the horizontal gene
transfer. H. influenzae is considered to be natural com-
petent, i.e., a bacterium capable of taking up exogenous
DNA and incorporating it into its own genetic material
by transformation [18,19]. These new genes incorporated
onto the genetic code may provide mechanisms to avoid
or inhibit the action of antimicrobial drugs. Even small
amino acid changes in proteins can enhance the resistance
of bacteria to drugs. One example is the Outer Membrane
Proteins (OMP) also known as porines, which in H. influen-
zae are classified from P1 to P6, in order of their decreas-
ing molecular weight (Figure 1) [20]. Small changes on the
amino acid sequence of one of these proteins were related
to an increase of antibiotics resistance in Haemophilus
influenzae strains isolated from cystic fibrosis patients
[21]. Porines isolated from resistant strains present a lower
electric conductibility than wild-type porines. This would
explain the non-susceptibility to beta-lactamic antibiotics
and other drugs with low molecular weight [22].
The use of organic and inorganic nanomaterials is now-
adays a new promising tool to biomedical researches, as
for example in cancer treatment and diagnostics, drug
delivery systems and bacterial processes [23]. Researchesd magnification of graphene oxide (in A: panoramic view,
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formation process can be influenced by nanoparticles, es-
pecially mesoporous silica and carbon nanotubes [24-26].
Graphene oxide nanoparticles (GON), a layered structure
of oxidized graphene sheets with epoxy- and hydroxyl
groups at their edges, is a new material that attracts atten-
tion due to their distinct electronic, thermal and mechan-
ical properties [27,28]. However, their potential role on
bacterial transformation is still unknown. As graphene is
composed by carbon atoms, it shows similar chemical
characteristics to nanoparticles present in the atmosphere
of highly polluted regions, provoking respiratory disorders
when these particles are inhaled.
This work aimed to see the effect of grapheme oxide
nanoparticles on the transformation frequency of H. influen-
zae; especially on the horizontal transfer of ompP2 amplicon
obtained from NTHi serotype 07, resistant to chlorampheni-
col and tetracycline; as well as to verify the adhesion of
mutant and wild-type strains on cells A549 and Hec-1-B
in the presence of antibiotics.
Methods
Bacterial strains
All strains used in this work are listed in Table 1. H. influ-
enzae strains were grown in chocolate agar or BHI agar
(Difco) supplemented with NAD (Sigma, Saint Louis, MO,
USA) 0,2 mg/ml and hemin (Sigma, Saint Louis, MO,
USA) 2 mg/ml at 37°C with 5% CO2 for 18–24 hours.
Cell cultures
Cell lines A549 (pulmonary epithelial carcinoma) and Hec-
1-B (human endometrium adenocarcinoma) were obtained
at the Institute Adolfo Lutz, Brazil. They were cultivated at
RPMI medium 1640 (Cultilab, Campinas, Brazil) with 10-
20% Bovine Fetal Serum (BFS), depending the cellular
lineage, and maintained at 37°C with 5% CO2. After theTable 1 Bacterial strains used in this work
Strains Characteristics
Rd Haemophilus influenzae standard strain compl
Hib-βlac Haemophilus influenzae serotype b ATCC
Hi07 Haemophilus influenzae NTHi - CmR, TcR, ApR
Hi38 Haemophilus influenzae serotype a isolated fro
Hi13 Haemophilus influenzae NTHi hmw+
Hi45 Haemophilus influenzae serotype b isolated fro
Hi46 Haemophilus influenzae serotype b isolated fro
Hi47 Haemophilus influenzae NTHi isolated from a h
Hic Haemophilus influenzae serotype c ATCC 9007
Hie Haemophilus influenzae serotype e NCTC 1047
Hif Haemophilus influenzae serotype f NCTC 7918.
IAL – Adolfo Lutz Institute SP, INCQS – FIOCRUZ – National Institute of Quality Cont
LABIOTEC – Biotechnology Laboratory – IB – UNICAMP.semiconfluent cell layer formation, the cells were trypsi-
nized and transferred to a 24-well polystyrene plate. Each
well received 1 ml of cell culture and the cell concentration
after its trypsinization was 1.106 cells/ml. Cells were incu-
bated under same conditions as previously described.
Graphene oxide nanoparticles synthesis
Graphene oxide nanoparticles were prepared after a cata-
lytic conversion using a cupper substratum. 1 ml of a poly-
aniline diluted in dimethylformamide was added on the
substratum and dried in room temperature for two hours.
On the substratum with polyaniline was put 0,2 ml of a
solution of nickel nitrate diluted in acetone. Cupper sub-
stratum was immersed into a chemical vapor deposition
reactor assisted by a hot filament. The reactor contained
a carbon source formed by camphor, acetone and citric
acid. Raman spectrometry and Field Emission Scanning
Electron Microscopy can be seen in Figure 2.
ompP2 gene amplification
Genomic DNA from H. influenzae strain NTHi 07 was
extracted using the protocol described by Sambrook et al.
[29]. The sequence of the gene ompP2 was obtained
at Genbank GI:2981106 (http://www.ncbi.nlm.nih.gov/
nucleotide). Primers used to gene amplification are listed
in Table 2.
Transformation process
Grown bacteria were transferred to BHI broth supple-
mented with NAD 2 μg/ml and hemin 10 μg/ml at a final
concentration of D600 1,0. Transformation process was
made using 100 μl of bacterial solution incubated with
5 μl of ompP2 amplicon at a concentration of 1 μg/ml,
followed by the addition of 15 μl of graphene oxide nano-
particles at a concentration of 20 μg/ml for 30 minutes.
Afterwards, 1 ml of supplemented BHI broth was addedOrigin
etely sequenced, from sorotype d INCQS – FIOCRUZ
INCQS – FIOCRUZ
LABIOTEC
m a pneumonia case LABIOTEC
LABIOTEC
m an hemoculture LABIOTEC
m a hemoculture LABIOTEC
emoculture LABIOTEC
NCTC 8469. IAL – SP
9. IAL – SP
IAL – SP
ol - Oswaldo Cruz Foundation.
Figure 2 Transformation frequency with and without the presence of Graphene Oxide Nanoparticles, with p < 0,001 (***).
Table 2 Primers used
Primer Nucleotids sequence 5′- 3′ Description
PorHi Fw ATTAATCGTTGGTGCATTCG porHi forward
Por Hi Rev GAAGTAAACGCGTAAACCTACAC porHi reverse
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CO2 for 3 hours. An aliquot of 100 μl was then trans-
ferred to BHI agar plate containing 2 μg/ml of chlor-
amphenicol and incubated for 18 hours under the same
described conditions. Negative control was made without
the use of nanoparticles. Transformed CFU were count
and statistical analysis was made by comparing the number
of transformants obtained with and without the use of
nanoparticles. To verify the successful gene acquisition, a
PCR was made under the same conditions as previously
described.
Cytotoxicity assay
Cytotoxicity tests were made to analyze whether the
antibiotic present in bacterial medium would interfere
on cellular growth. After 24 hours of incubation, the
medium was removed, the wells were washed 3 × with
0.1 mL of PBS Buffer (137 mM NaCl, 10 mM phosphate,
KCl 2.7 mM, and a pH of 7.4). 0.2 mL of RPMI1640 was
added in each well. An initial concentration of chloram-
phenicol of 4 μg/ml was added into the first wells and
diluted into half concentration in each well. After incu-
bation for 3 h at 37°C, the medium with dye was
removed and carefully 0.2 mL of ethanol was added to
solubilize the blue formazan (yielded from MTT reduction
by viable cells). The plates were shaken for 10 minutes
and the absorbance for each well was read in a spectropho-
tometer ELx800 Absorbance Microplate Reader (BioTek,
USA) at λ = 570 nm. The values were expressed as percent-
ages of MTT reduction compared to the control, where
cells were not exposed to test agents [30].Neutral red (NR) uptake assay
The Neutral Red uptake assay was performed as described
[31]. After incubation, the medium containing the dye was
removed and the wells were rapidly washed with 0.2 ml of
calcium-formaldehyde solution (10 ml of 40% formalde-
hyde, 10 ml of CaCl2; 10 ml deionized water). The solu-
tion was discarded and 0.2 mL of ethanol-acetic acid was
added (1 ml of glacial acetic acid, 100 ml of ethanol 50%).
The plate was kept for 15 minutes at room temperature
and the absorbance for each well was read in a spec-
trophotometer ELx800 Absorbance Microplate Reader
(BioTek, USA) at λ=540 nm [32]. The values were expressed
as percentages of NR uptake compared to the control, in
which the cells were not exposed to test agents.
Adhesion assay
Adhesion assay on cells was performed based on the
description of Scaletsky et al. [33]. 50 μl of bacterial
suspension with a concentration of 1.106 CFU/ml was
added into each well containing 1 ml of RPMI 1640 with
10% BFS and 2 μg/mL of chloramphenicol. After an in-
cubation period of 3 hours at 37°C with 5% CO2, cellular
medium was removed and each well was washed five
times with RPMI 1640, to remove bacteria that did not
adhere to the cells. 1 ml of RPMI was added to each
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tip to release adhered bacteria. An aliquot of 50 μl
was taken and plated into chocolate agar medium with
chloramphenicol for the mutant strain and without the
antibiotic for wild-type strains. The plates were incu-
bated for 18 hours at 37°C with 5% CO2 and CFU were
counted.
Statistical analysis
Statistical analysis was performed using GraphPad Instat
program: transformation efficiency was analyzed by
Bonferroni test with the number of CFU transformants
with and without the presence of graphene oxide nanopar-
ticles. Considered values were p < 0.05. The adhesion assay
was analyzed by Tukey’s test with a comparison of a
control sample. All experiments were made in triplicate.
Results and discussion
Transformation process and resulting frequencies
The graphic of transformation frequencies with and
without the use of nanoparticles for each H. influenzae
strain is shown in Figure 3. As we can see, the transform-
ation frequencies vary among the strains. Hi38, Hi45, HiF,
Hiβlac and HiRd presented an increased transformation
frequency with the presence of GON, whereas for the
strains Hi13 and Hi47 these values were decreased. How-
ever, the only strain that presented an extremely signifi-
cant value of p < 0.001 is H. influenzae 38, as shown in
Table 3.
The verification of ompP2 incorporation into the gen-
omic DNA of the receptor strains was made by PCR
analysis (data not shown). Studies of how nanoparticles
effect transformation processes have already been made,
proving to have an increase on its frequency. One hypo-
thetical mechanism for this phenomenon could be ex-
plained by a complexation of the nanomaterial with DNA,
avoiding its degradation by DNAse enzymes. The uptake
of DNA and its incorporation into bacterial genetic mater-
ial could be facilitated by these nanoparticles [24,25].Figure 3 Citotoxicity in A549 and Hec1B cell lines.GON are found in high concentration in polluted atmo-
spheres, especially in arid regions. This way, the study of
their influence on H. influenzae transformation mimics a
natural environment of carbon nanoparticles in the at-
mosphere, helping the transformation process in bacteria
that asymptomatically colonizes the upper respiratory
tract in humans. In certain regions were primitive agricul-
ture is practiced, performed by sugar cane burning, the
resulting emission of micro and nanoparticles generate a
major series of respiratory complications and infections
[34]. This way, the only strain which presented a statisti-
cally significant increase of transformation frequency is
H. influenzae 38. Interestingly, this strain distinguishes
itself from the other studied strains by being clinically
isolated from a pneumonia sample (Table 1); because of
that, this bacterium can be more adapted to a carbon
nanoparticle-concentrated atmosphere and therefore m
use them in its own favor than strains isolated from blood
cultures. As graphene oxide nanoparticles present a similar
structure and physical-chemical characteristics than multi-
walled carbon nanotubes and mesoporous silica nanoparti-
cles, it is believed that these nanostructures share the same
action mechanisms in transformation processes. Therefore,
the same hypothesis previously presented can be applied
to explain the major increase of transformation frequency
of H. influenzae strain 38 with the presence of graphene
oxide nanoparticles.
Cytotoxicity
Graphics of cellular viability under the effects of chloram-
phenicol results are shown in Figure 4. The highest con-
centration (4 μg/ml) led to a decrease of 20% for Hec-1-b
and A549. For the concentration of 2 μg/ml used in the ad-
hesion assay, the cell viability resulted in 83%, thus chlor-
amphenicol is not considered toxic under these conditions.
Adhesion assay
The graphics of cellular adhesion for wild-type and mu-
tant strains in A549 and Hec1B cells with and without
Table 3 Transformation tax value per colony forming
unit and standard deviation
Strains CFU STD
Hi13 24.667 3.786
Hi13 gon 16 5
Hi38 31.333 7.234
Hi38 gon 106 14.177
Hi45 23 7.937
Hi45 gon 33.33 3.215
Hi47 14.33 1.528
Hi47 gon 8.667 3.215
HiF 75.667 16.258
HiF gon 80 12.49
Hiβlac 62 18.52
Hiβlac gon 73.33 22.301
HiRd 10.33 4.041
HiRd gon 40 26.889
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Wild-type strains of H. influenzae did not present any
statistical relevant values for adhesion in A549 cells with
or without the presence of antibiotics, while mutant
strains C and βlac show an increase of adhesion whenFigure 4 Adhesion patterns of wild and mutated strains of H. influen
p < 0,005 (**) and p < 0,001(***).chloramphenicol was added, resulting into a significant
ρ value of p < 0.05. By comparing wild-type and mutant
strains, the adhesion of the first ones with and without
chloramphenicol in A549 cells had an increase of p <
0.05 and p < 0.001, respectively.
As for the adhesion results in Hec1B cells, mutant
strain Hi13M showed an increase of its adhesion in the
presence of antibiotics when compared to the adhesion
with its absence, with p < 0.05. In an environment without
chloramphenicol, Hi46M also had an increase with a sig-
nificant value of p < 0.05 compared to its wild-type strain.
The comparison between wild-type and mutant strains
with antibiotics presence revealed a clear increase of adhe-
sion by the mutant strains. H. influenzae 13, 47, C and
βlac mutant and wild-type strains presented an extremely
significant p value of < 0.001, while 46 strain had a very
significant value of p < 0.01.
The adhesion assay to see the influence of mutation of
ompP2 gene was proposed due to the importance of bac-
terial adherence at the mucosal surface on host organisms
as a virulence factor [33]. The pulmonary adenocarcinoma
cell lineage A549 was chosen due to H. influenzae predi-
lection of respiratory tract [31], while Hec1B cells of endo-
metrial adenocarcinoma were used with the purpose of
mimetizing an endothelium [35]. As cytotoxicity results
presented a cellular viability of over 80% at the highestzae in A549 cell line. With atb- antibiotic, M- mutated, p < 0,05(*),
Figure 5 Adhesion patterns of mutated and wild strains of H. influenzae in Hec1B cell line. Atb- antibiotic, M- mutated, p < 0,05(*),
p < 0,005 (**) and p < 0,001(***).
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not affect the cellular growth of neither A549 nor Hec1B
lineages. ompP2 provides H. influenzae with resistance to
chloramphenicol, thus the presence of this antibiotic in
the medium increases the gene expression in mutant
strains, at the same time it inhibits the bacterial growth in
wild-type strains. Therefore, it was already expected that
mutant strains presented a higher adhesion in cell cultures
than wild-type ones. Nonetheless, the adhesion taxes with-
out the presence of antibiotics also presented increased re-
sults for the majority of mutant strains, with a significant
value of p < 0.05 for Hi47M, HiCM and HiβlacM in A549
cells, while all mutant variants showed highly significant
ρ values of p < 0.01 and p < 0.001 in Hec1B cells.
Bacterial strains presented different adhesion taxes on
A549 and Hec1B cells. While all mutant strains showed
a major adhesion with and without antibiotics in Hec1B
cells, with a significant ρ value when compared to their
wild-type, this behavior could not be seen in A549 cells.
One possible explanation is the fact that H. influenzae is
a commensal bacterium of the upper respiratory tract and
therefore wild-type strains present a natural capability of
adhesion on these cells. On the other hand, these bac-
teria only have contact with endothelial cells in meningi-
tis cases. As this microenvironment does not permit adirect transition from one host to another, the adhesion
on Hec1B does not present any natural evolutionary po-
tential for H. influenzae [36,37]. The acquisition of ompP2
gene obtained from Hi07 strain not only provided a resist-
ance to chloramphenicol, but also increased the adhesion
taxes especially in Hec1B cells.
H. influenzae type b P2 porine (341 amino acids, 37.782 Da)
allows the diffusion of small molecules with a molecular
weight of until 14000 Da to the periplasmatic space [38].
This is probably the antibiotics way of access into the bac-
terial cell. Small changes on the amino acid configuration
provide different molecule captures by closing the canal,
therefore modifying the porine function [39]. The basic
amino acid changes in the porine overture loop domains 1
and 3 could difficult the penetration of chloramphenicol
to the inner side of H. influenzae, resulting into a resist-
ance to this antibiotic and also into a better adhesion to
cell cultures.
The adhesion of mutant H influenzae strains on human
cells surface is directly linked to the influence of graphene
oxide nanoparticles on bacterial transformation, once the
resulting mutants presented a higher adhesion to cell lines
compared to wild type strains. Some studies have already
related atmospheric pollution to cases of bacterial menin-
gitis [40,41]. Therefore, this study corroborates to the
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naturally competent bacteria to the influence of nanopar-
ticles and its consequences to the health of people
exposed to them, especially in polluted and arid regions.
Conclusions
Graphene oxide nanoparticles aid the transformation
process, helping to increase the number of CFUs, and
the mutants generated with the ompP2 gene from a H.
influenzae resistant strain not only present an chloram-
phenicol resistance but also have an increased adherence
patterns in A549 and Hec1B cell lines. Also, the increase
of transformation frequency have some relationships with
the adhesion, or the virulence of this bacterium. Then a
gene liked to antibiotic resistance acquisition showed a
great capacity of not only antibiotic transference charac-
teristics between H. influezae strains as the transference of
the virulence factors present in different strains in human
upper respiratory tract.
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